Professional Treatment Protocol

Preparation
1. Open Vial 1 containing the lyophilised powder.
2. Add Vial 2 diluent to Vial 1.
3. Gently shake until the powder is dissolved.
4. Use immediately after mixing.
Application
RENOXOME+ is intended for use within a professional skin-treatment protocol.
The product may be applied to cleansed and disinfected skin, with the treatment performed using an appropriate professional technique and device according to the practitioner’s protocol and applicable regulations.
A calming mask or recovery gel may be applied after treatment to help soothe the skin.

Microneedling Depth Guidelines

Sensitive Skin
0.15–0.5 mm
For barrier support, hydration, and mild post-procedure support.
Early Signs of Ageing / Dullness
0.25–0.3 mm
For general skin revitalisation and texture support.
Healed Acne Scars / Texture
Up to 0.5 mm
For professional protocols targeting the appearance of healed acne scars and uneven texture.
Treatment depth should always be selected by a qualified professional based on skin condition, treatment objective, device specifications, and applicable local regulations.

20250620_RenoXome+_PPT_ENG_compressed_compressed (1)_page-0021
01
TREATMENT FREQUENCY

Recommended Treatment Frequency

General Rejuvenation / Early Ageing

Every 2–3 weeks

4–6 sessions

Sensitive Skin / Barrier Support

Every 3–4 weeks

3–5 sessions

Post-Treatment Support

Every 2–4 weeks

3–5 sessions

Acne Scarring

Every 2–3 weeks

5–7 sessions

Maintenance

Every 4–6 weeks

As needed

Treatment schedules should be personalised by a qualified practitioner.

02
AFTERCARE

Aftercare

The First 24–48 Hours

Following treatment:

  • Avoid makeup
  • Avoid excessive heat
  • Avoid intense sun exposure
  • Avoid potentially irritating or active skincare ingredients
  • Follow the practitioner's recovery instructions
  • Begin using SPF 50+ from the following day

The skin may temporarily appear red or feel warm, tight, dry, or sensitive following treatment.

Contraindications & Precautions

RENOXOME+ should not be used in professional treatment protocols where any of the following apply unless specifically cleared by an appropriate healthcare professional:
• Active skin infections
• Open wounds or healing cuts
• Active or cystic acne
• History of keloid or hypertrophic scarring
• Severe rosacea or active eczema flare-ups
• Blood-clotting disorders
• Anticoagulant use
• Autoimmune skin diseases
• Known allergy or sensitivity to any ingredient
• Recent chemical peel or laser treatment
• Diabetes or impaired wound healing
A professional assessment should be performed before treatment.

Expected Temporary Reactions

Temporary reactions may include:
• Redness
• Mild warmth or tingling
• Tightness or dryness
• Mild swelling
• Itching, particularly in dry or sensitive skin
• Light flaking or peeling
• Temporary increased sensitivity
These reactions may vary depending on the individual’s skin condition and treatment procedure.
Persistent, severe, or unexpected reactions should be assessed by a qualified healthcare professional.

01
STORAGE & SHELF LIFE

Storage & Shelf Life

Package

1 box containing 2 vials

  • Vial 1: Lyophilised Powder — 160 mg
  • Vial 2: Diluent — 6 mL

Shelf Life

2 years when stored under recommended conditions.

Storage Conditions

Store at:

2°C–8°C

Keep away from:

  • Direct sunlight
  • Heat
  • Humidity

Important

Do not use the product if either vial shows signs of:

  • Significant discolouration
  • Sediment
  • Cloudiness
  • Other visible changes indicating possible product instability

Improper storage may affect the colour, clarity, stability, and quality of the product.

02
PRODUCT OVERVIEW

RENOXOME+ at a Glance

Feature
RENOXOME+
Core Technology
Centella Asiatica Leaf Vesicles + PDRN
Plant Source
Centella Asiatica Leaves
Exosome Content
8 Billion purified plant-derived exosomes*
Form
Dual-vial formulation
Vial 1
Lyophilised Powder
Vial 2
Diluent
Powder Weight
160 mg
Diluent Volume
6 mL
Storage
2°C–8°C
Shelf Life
2 years
Intended Application
Professional skin-recovery protocols

*As stated in the product specification. Final website claims should be verified against the manufacturer's current technical documentation and certificate of analysis.

Frequently Asked Questions

RENOXOME+ is a professional skin-recovery formulation combining purified Centella Asiatica Leaf Vesicles with PDRN, hyaluronic acid, vitamins, antioxidants, minerals, and other skin-supporting ingredients.

They are plant-derived extracellular vesicles obtained from Centella Asiatica leaves. They are incorporated into RENOXOME+ as part of its regenerative and skin-supporting technology.

PDRN, or Sodium DNA, is a polynucleotide-based ingredient studied for its role in tissue recovery, cellular activity, and skin regeneration.

The formulation is designed for professional protocols targeting concerns such as dehydration, dullness, fine lines, uneven texture, weakened barrier function, and the appearance of healed acne scars.

Treatment frequency depends on the skin condition and treatment objective. Protocols may range from every 2–4 weeks during an initial treatment course, followed by maintenance sessions as required.

It may be incorporated into protocols for sensitive or barrier-compromised skin, but treatment should be customised by a qualified professional. Active inflammation, infection, or other contraindications should be ruled out first.

Store between 2°C and 8°C, protected from direct sunlight, heat, and humidity.

The dual-vial format is designed to help protect heat- and moisture-sensitive ingredients and maintain formulation stability until preparation.

Science Behind RENOXOME+

Referenced Research

Kim, M., Yoon, E., Kim, J., Park, S., Lee, H. (2023).

Comparative analysis of the transcriptome and efficacy of bioactive Centella asiatica exosomes on skin cells.

The referenced research investigated Centella Asiatica-derived exosomes and extract in laboratory skin-cell models, including collagen-related gene expression, MMP1, wound recovery, and inflammatory signalling.

Research findings should be interpreted as laboratory evidence and should not be considered equivalent to clinical efficacy of the finished RENOXOME+ product unless supported by product-specific clinical studies.

Science Behind RENOXOME+

Nature. Science. Regeneration.

RENOXOME+ brings together:

8 Billion Plant-Derived Exosomes

PDRN

Hyaluronic Acid

Vitamins & Antioxidants

Collagen & Skin-Supporting Nutrients

Dual-Vial Stability Technology

Science Behind RENOXOME+

Referenced Research

Kim, M., Yoon, E., Kim, J., Park, S., Lee, H. (2023).
Comparative analysis of the transcriptome and efficacy of bioactive Centella asiatica exosomes on skin cells.

The referenced research investigated Centella Asiatica-derived exosomes and extract in laboratory skin-cell models, including collagen-related gene expression, MMP1, wound recovery, and inflammatory signalling.

Research findings should be interpreted as laboratory evidence and should not be considered equivalent to clinical efficacy of the finished RENOXOME+ product unless supported by product-specific clinical studies.
Why Choose RENOXOME?

One Comprehensive Approach to Skin Recovery

Support regeneration.
Restore hydration.
Strengthen the barrier.
Calm stressed skin.
Reveal a healthier-looking complexion.
Professional Use

Professional Use

RENOXOME+ is developed for incorporation into professional aesthetic and skin-recovery protocols.

Treatment should be performed by appropriately trained professionals in accordance with applicable local regulations, product instructions, and professional standards.